東華大學圖書館 |

The end of Alzheimer's : = the brain and beyond /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The end of Alzheimer's :/ Thomas J. Lewis and Clement L. Trempe.
其他題名:	the brain and beyond /
作者:	Lewis, Thomas J.,
其他作者:	Trempe, Clement L.,
面頁冊數:	1 online resource (484 p.) :illustrations.
附註:	Description based upon print version of record.
內容註:	Cover; Title page; Copyright page; Dedication; Contents; About the Authors; Foreword; By Jack C. de la Torre, MD, PhD; By Kimer S. McCully, MD; Preface; By Dr. Lewis; By Dr. Trempe; Chapter 1 -- Is it Alzheimer's Disease?; Neurodegenerative Diseases and Dementia; True Dementias; Alzheimer's Disease; Alzheimer's Versus Dementias; Multifactorial Alzheimer's; What if Alzheimer's Is Not Isolated to the Brain?; Differential Diagnosis; Beta-Amyloid and Alzheimer's; Diseases That Occur With Alzheimer's; Impact of Alzheimer's; Treatable Dementias and "Senior Moments"; Head Injury; Acute Infections.
內容註:	Normal Pressure HydrocephalusSimple Hydrocephalus; Brain Tumors; Toxic Exposure; Metabolic Disorders; Hormone Disorders; Poor Oxygenation (Hypoxia); Blood Pressure; Drug Reactions, Overuse, or Abuse; Nutritional Issues; Sodium Deficiency; Chronic Alcoholism; Other Neurodegenerative Disorders; Vascular Dementia; Parkinson's Disease; Lewy Body Dementia; Huntington's Disease; Creutzfeldt-Jakob Disease; Pick's Disease (Frontotemporal Dementia); Conclusions; References; Chapter 2 -- The Amyloid Cascade Hypothesis; Evidence Against the Amyloid Cascade Hypothesis.
內容註:	Research Opposed to the Amyloid Cascade HypothesisDrug Companies Committed to the Amyloid Hypothesis; Eli Lilly; Johnson & Johnson and Pfizer; Bristol-Myers Squibb; Pfizer and Medivation; Merck; The Animal Model for Alzheimer's and Beta-Amyloid Therapy; If Not Amyloid, What Next?; What Use Does Amyloid Serve? Diagnostics; Tau-Neurofibrillary Tangles: The "Other" Hallmark; Proposed Tau Therapies; Hyperphosphorylated Tau Occurs Naturally in Healthy Animals; References; Chapter 3 -- Diagnosis of Alzheimer's-Standard-of-Care; Alzheimer's Diagnosis: Standard-of-Care; Mental Status Tests.
內容註:	Mini-Mental State ExaminationMini-Cog; Mood Assessment; Brain Imaging; Objective Evaluation: Standard-of-Care; The First Alzheimer's Diagnosis; Standard-of-Care Diagnosis at Autopsy; Cognitive Tests and Human Memory; Cognitive Functioning Tests Explored; The Mini-Mental State Examination; Neurological Tests Beyond the MMSE; Limits of Cognitive Tests; Advanced Diagnosis Within the Standard-of-Care; Advanced Brain Imaging; Magnetic Resonance Imaging; Positron Emission Tomography; X-Ray Computer Tomography Scan; Who Creates Diagnostic Criteria?; References; Chapter 4 -- Diagnostic Accuracy.
內容註:	Diagnosis ExploredMisdiagnosis; Prevalence of Misdiagnosis; Why Does Misdiagnosis Occur?; Patient; Doctor; Doctors Are Not the Problem; Causes of Misdiagnosis; Preventing Misdiagnosis; A 300-Billion Diagnostic Error; Baseline Disease 1-Pellagra; Baseline Disease 2-Tuberculosis; Baseline Disease 3-Typhoid Fever; Statins and Cardiovascular Disease; Statins Trigger Memory Problems; Link Between Low Cholesterol and Mortality; Cholesterol and Alzheimer's Disease; Misdiagnosis: Case Study; References; Chapter 5 -- Can Medicine Save You?; Do We Need Drugs to Be Healthy?
標題:	Alzheimer's disease. -
電子資源:	https://www.sciencedirect.com/science/book/9780128121122
ISBN:	9780128121139

The end of Alzheimer's : = the brain and beyond /
Lewis, Thomas J.,

The end of Alzheimer's :the brain and beyond /Thomas J. Lewis and Clement L. Trempe. - Second edition. - 1 online resource (484 p.) :illustrations.

Description based upon print version of record.

Includes bibliographical references and index.

Cover; Title page; Copyright page; Dedication; Contents; About the Authors; Foreword; By Jack C. de la Torre, MD, PhD; By Kimer S. McCully, MD; Preface; By Dr. Lewis; By Dr. Trempe; Chapter 1 -- Is it Alzheimer's Disease?; Neurodegenerative Diseases and Dementia; True Dementias; Alzheimer's Disease; Alzheimer's Versus Dementias; Multifactorial Alzheimer's; What if Alzheimer's Is Not Isolated to the Brain?; Differential Diagnosis; Beta-Amyloid and Alzheimer's; Diseases That Occur With Alzheimer's; Impact of Alzheimer's; Treatable Dementias and "Senior Moments"; Head Injury; Acute Infections.

The End of Alzheimer's: The Brain and Beyond, Second Edition is the first comprehensive overview on the molecular basis of Alzheimer's outside of the brain, merging the most recent findings within the field into a single book. It aims to educate the reader on the many overlooked aspects of Alzheimer's disease that occur outside the brain. This book uniquely provides step-by-step, peer-reviewed evidence that the current research model may be misguided and that a new and emerging model is more accurate. It carefully outlines the molecular research in Alzheimer's outside the brain and argues that a more thorough, whole-body diagnosis will provide better answers about its causes and lead to new treatments. It is beneficial to researchers who need to be apprised of the emerging science on the causes of Alzheimer's, and will hopefully redirect many into new avenues of cellular research and discovery.

ISBN: 9780128121139Subjects--Topical Terms:

588010
Alzheimer's disease.
Index Terms--Genre/Form:

542853
Electronic books.

LC Class. No.: RC523

Dewey Class. No.: 616.8/311

The end of Alzheimer's : = the brain and beyond /
LDR:05162cmm a2200385 i 4500 001 2185669
006 m o d
007 cr cnu|||unuuu
008 200116s2017 enka ob 001 0 eng d
020 $a 9780128121139 $q (electronic bk.)
020 $a 0128121130 $q (electronic bk.)
020 $a 9780128121122
020 $a 0128121122
035 $a (OCoLC)987725951 $z (OCoLC)987345943 $z (OCoLC)987432825
035 $a els69900513
040 $a EBLCP $b eng $e rda $e pn $c EBLCP $d YDX $d N$T $d IDEBK $d OCLCF $d OCLCQ $d TEFOD $d OPELS $d TKN $d MERER $d OCLCQ $d UPM $d CASUM $d OCLCQ $d OCLCO $d OCLCQ $d OCLCA $d USU $d D6H $d OCLCO $d DKU $d OCLCO
041 0 $a eng
050 4 $a RC523
082 0 4 $a 616.8/311 $2 23
100 1 $a Lewis, Thomas J., $e author. $3 3399016
245 1 4 $a The end of Alzheimer's : $b the brain and beyond / $c Thomas J. Lewis and Clement L. Trempe.
250 $a Second edition.
264 1 $a London : $b Academic Press, an imprint of Elsevier, $c [2017]
300 $a 1 online resource (484 p.) : $b illustrations.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Description based upon print version of record.
500 $a The Commercialization of Health Care.
504 $a Includes bibliographical references and index.
505 0 $a Cover; Title page; Copyright page; Dedication; Contents; About the Authors; Foreword; By Jack C. de la Torre, MD, PhD; By Kimer S. McCully, MD; Preface; By Dr. Lewis; By Dr. Trempe; Chapter 1 -- Is it Alzheimer's Disease?; Neurodegenerative Diseases and Dementia; True Dementias; Alzheimer's Disease; Alzheimer's Versus Dementias; Multifactorial Alzheimer's; What if Alzheimer's Is Not Isolated to the Brain?; Differential Diagnosis; Beta-Amyloid and Alzheimer's; Diseases That Occur With Alzheimer's; Impact of Alzheimer's; Treatable Dementias and "Senior Moments"; Head Injury; Acute Infections.
505 8 $a Normal Pressure HydrocephalusSimple Hydrocephalus; Brain Tumors; Toxic Exposure; Metabolic Disorders; Hormone Disorders; Poor Oxygenation (Hypoxia); Blood Pressure; Drug Reactions, Overuse, or Abuse; Nutritional Issues; Sodium Deficiency; Chronic Alcoholism; Other Neurodegenerative Disorders; Vascular Dementia; Parkinson's Disease; Lewy Body Dementia; Huntington's Disease; Creutzfeldt-Jakob Disease; Pick's Disease (Frontotemporal Dementia); Conclusions; References; Chapter 2 -- The Amyloid Cascade Hypothesis; Evidence Against the Amyloid Cascade Hypothesis.
505 8 $a Research Opposed to the Amyloid Cascade HypothesisDrug Companies Committed to the Amyloid Hypothesis; Eli Lilly; Johnson & Johnson and Pfizer; Bristol-Myers Squibb; Pfizer and Medivation; Merck; The Animal Model for Alzheimer's and Beta-Amyloid Therapy; If Not Amyloid, What Next?; What Use Does Amyloid Serve? Diagnostics; Tau-Neurofibrillary Tangles: The "Other" Hallmark; Proposed Tau Therapies; Hyperphosphorylated Tau Occurs Naturally in Healthy Animals; References; Chapter 3 -- Diagnosis of Alzheimer's-Standard-of-Care; Alzheimer's Diagnosis: Standard-of-Care; Mental Status Tests.
505 8 $a Mini-Mental State ExaminationMini-Cog; Mood Assessment; Brain Imaging; Objective Evaluation: Standard-of-Care; The First Alzheimer's Diagnosis; Standard-of-Care Diagnosis at Autopsy; Cognitive Tests and Human Memory; Cognitive Functioning Tests Explored; The Mini-Mental State Examination; Neurological Tests Beyond the MMSE; Limits of Cognitive Tests; Advanced Diagnosis Within the Standard-of-Care; Advanced Brain Imaging; Magnetic Resonance Imaging; Positron Emission Tomography; X-Ray Computer Tomography Scan; Who Creates Diagnostic Criteria?; References; Chapter 4 -- Diagnostic Accuracy.
505 8 $a Diagnosis ExploredMisdiagnosis; Prevalence of Misdiagnosis; Why Does Misdiagnosis Occur?; Patient; Doctor; Doctors Are Not the Problem; Causes of Misdiagnosis; Preventing Misdiagnosis; A 300-Billion Diagnostic Error; Baseline Disease 1-Pellagra; Baseline Disease 2-Tuberculosis; Baseline Disease 3-Typhoid Fever; Statins and Cardiovascular Disease; Statins Trigger Memory Problems; Link Between Low Cholesterol and Mortality; Cholesterol and Alzheimer's Disease; Misdiagnosis: Case Study; References; Chapter 5 -- Can Medicine Save You?; Do We Need Drugs to Be Healthy?
520 $a The End of Alzheimer's: The Brain and Beyond, Second Edition is the first comprehensive overview on the molecular basis of Alzheimer's outside of the brain, merging the most recent findings within the field into a single book. It aims to educate the reader on the many overlooked aspects of Alzheimer's disease that occur outside the brain. This book uniquely provides step-by-step, peer-reviewed evidence that the current research model may be misguided and that a new and emerging model is more accurate. It carefully outlines the molecular research in Alzheimer's outside the brain and argues that a more thorough, whole-body diagnosis will provide better answers about its causes and lead to new treatments. It is beneficial to researchers who need to be apprised of the emerging science on the causes of Alzheimer's, and will hopefully redirect many into new avenues of cellular research and discovery.
650 0 $a Alzheimer's disease. $3 588010
655 4 $a Electronic books. $2 lcsh $3 542853
700 1 $a Trempe, Clement L., $e author. $3 3399017
856 4 0 $u https://www.sciencedirect.com/science/book/9780128121122